FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094587340> ?p ?o ?g. }

• W3094587340 endingPage "e718" @default.
• W3094587340 startingPage "e718" @default.
• W3094587340 abstract "Brain metastases (BM) are frequent in non-small cell lung cancer patients with driver mutations (dm-NSCLC). Since the availability of brain-penetrating tyrosine kinase inhibitors (TKI), the role of local therapy (LT) for BM from dm-NSCLC is frequently discussed. This analysis examines prognostic factors, particularly the effect of LT timing and technique, in patients with BM from dm-NSCLC. Between 2009 and 2019, 179 patients from one institution were diagnosed with BM from dm-NSCLC and subsequently received TKI-therapy. 78.8% (n = 141) were TKI-naive and selected for analysis. 108 patients (76.6%) had Epidermal Growth Factor Receptor (EGFR) mutations with exon19 deletion most prevalent (n = 61, 56.5%); 33 (23.4%) showed translocation of the Anaplastic Lymphoma Kinase (ALK) gene. 75 patients (41.9%) presented with ≥5 BM. 87 patients (61.7%) received early LT, whereas 54 (38.3%) received delayed LT upon progression (n = 34; 24.1%) or none (n = 20; 14.2%). LT consisted of stereotactic radiosurgery (SRS) (n = 40; 34.2%) or whole brain radiotherapy (WBRT) (n = 77; 65.8%); neurosurgical resection was performed with (n = 15; 10.6%) or without (n = 4; 2.8%) post-operative radiotherapy (RT) in 19 cases. TKI treatment comprised first (n = 93; 66.0%), second (n = 31; 22.0%) or third generation substances (n = 17; 12.1%). A univariate and multivariate Cox proportional hazards model was fitted for overall survival (OS) and intracranial progression-free survival (icPFS). Median OS was 23.0 [IQR 14.6-54.5] months for all patients, 49.1 [IQR 22.7-NA] months for the ALK subgroup and 19.5 [IQR 12.8-46.3] months for the EGFR subgroup (HR 2.6, 95%CI: [1.5-4.7], p = 0.001). Median icPFS was 15.7 [8.9-26.2] months for all patients, 15.7 [10.3-26.2] months and 14.0 [7.9-22.0] months for the subgroups, respectively (HR 1.1, 95%CI: [0.6-1.8], p = 0.814). On multivariate analysis, early LT improved icPFS (HR 0.5, 95%CI: [0.3-0.9], p = 0.009) but not OS (HR 1.4, 95%CI: [0.9-2.3], p = 0.140). This effect was reproduced in independent analysis of the ALK subgroup, but not in the EGFR subgroup. Here, exon 19 deletion (HR 0.4, 95%CI: [0.2-0.8], p = 0.009) and singular BM (HR 0.4, 95%CI: [0.2-0.7], p = 0.002) were independently prognostic of longer icPFS. In the combined cohort, RT technique (SRS vs. WBRT) and number of BM did not influence icPFS or OS. In this analysis, early LT improved icPFS but not OS in TKI-naive patients with BM from dm-NSCLC, compared to upfront TKI treatment. No benefit was shown for WBRT over SRS regarding either icPFS or OS. In light of the toxicities of WBRT, the choice of RT technique should be considered carefully in the context of overall prognosis and quality of life. Especially patients presenting initially with multiple BM may benefit from delaying RT or from individualized approaches like the SRS of multiple or only selected BM instead of WBRT." @default.
• W3094587340 created "2020-10-29" @default.
• W3094587340 creator A5010144158 @default.
• W3094587340 creator A5010170241 @default.
• W3094587340 creator A5013804417 @default.
• W3094587340 creator A5025473299 @default.
• W3094587340 creator A5045520915 @default.
• W3094587340 creator A5047883361 @default.
• W3094587340 creator A5078996737 @default.
• W3094587340 creator A5080547151 @default.
• W3094587340 creator A5084960047 @default.
• W3094587340 date "2020-11-01" @default.
• W3094587340 modified "2023-09-27" @default.
• W3094587340 title "Optimal Timing And Technique Of Local Therapy For Brain Metastases From Non-Small Cell Lung Cancer With Driver Mutations" @default.
• W3094587340 doi "https://doi.org/10.1016/j.ijrobp.2020.07.096" @default.
• W3094587340 hasPublicationYear "2020" @default.
• W3094587340 type Work @default.
• W3094587340 sameAs 3094587340 @default.
• W3094587340 citedByCount "0" @default.
• W3094587340 crossrefType "journal-article" @default.
• W3094587340 hasAuthorship W3094587340A5010144158 @default.
• W3094587340 hasAuthorship W3094587340A5010170241 @default.
• W3094587340 hasAuthorship W3094587340A5013804417 @default.
• W3094587340 hasAuthorship W3094587340A5025473299 @default.
• W3094587340 hasAuthorship W3094587340A5045520915 @default.
• W3094587340 hasAuthorship W3094587340A5047883361 @default.
• W3094587340 hasAuthorship W3094587340A5078996737 @default.
• W3094587340 hasAuthorship W3094587340A5080547151 @default.
• W3094587340 hasAuthorship W3094587340A5084960047 @default.
• W3094587340 hasConcept C117643217 @default.
• W3094587340 hasConcept C121608353 @default.
• W3094587340 hasConcept C126322002 @default.
• W3094587340 hasConcept C143998085 @default.
• W3094587340 hasConcept C144301174 @default.
• W3094587340 hasConcept C2776232967 @default.
• W3094587340 hasConcept C2776256026 @default.
• W3094587340 hasConcept C2776694085 @default.
• W3094587340 hasConcept C2778164965 @default.
• W3094587340 hasConcept C2779013556 @default.
• W3094587340 hasConcept C2779438470 @default.
• W3094587340 hasConcept C2780387249 @default.
• W3094587340 hasConcept C2780739268 @default.
• W3094587340 hasConcept C38180746 @default.
• W3094587340 hasConcept C50382708 @default.
• W3094587340 hasConcept C509974204 @default.
• W3094587340 hasConcept C71924100 @default.
• W3094587340 hasConceptScore W3094587340C117643217 @default.
• W3094587340 hasConceptScore W3094587340C121608353 @default.
• W3094587340 hasConceptScore W3094587340C126322002 @default.
• W3094587340 hasConceptScore W3094587340C143998085 @default.
• W3094587340 hasConceptScore W3094587340C144301174 @default.
• W3094587340 hasConceptScore W3094587340C2776232967 @default.
• W3094587340 hasConceptScore W3094587340C2776256026 @default.
• W3094587340 hasConceptScore W3094587340C2776694085 @default.
• W3094587340 hasConceptScore W3094587340C2778164965 @default.
• W3094587340 hasConceptScore W3094587340C2779013556 @default.
• W3094587340 hasConceptScore W3094587340C2779438470 @default.
• W3094587340 hasConceptScore W3094587340C2780387249 @default.
• W3094587340 hasConceptScore W3094587340C2780739268 @default.
• W3094587340 hasConceptScore W3094587340C38180746 @default.
• W3094587340 hasConceptScore W3094587340C50382708 @default.
• W3094587340 hasConceptScore W3094587340C509974204 @default.
• W3094587340 hasConceptScore W3094587340C71924100 @default.
• W3094587340 hasIssue "3" @default.
• W3094587340 hasLocation W30945873401 @default.
• W3094587340 hasOpenAccess W3094587340 @default.
• W3094587340 hasPrimaryLocation W30945873401 @default.
• W3094587340 hasRelatedWork W1728161349 @default.
• W3094587340 hasRelatedWork W1966681552 @default.
• W3094587340 hasRelatedWork W1998259048 @default.
• W3094587340 hasRelatedWork W2156980712 @default.
• W3094587340 hasRelatedWork W2361700749 @default.
• W3094587340 hasRelatedWork W2508468768 @default.
• W3094587340 hasRelatedWork W2516942920 @default.
• W3094587340 hasRelatedWork W2747510197 @default.
• W3094587340 hasRelatedWork W2794733391 @default.
• W3094587340 hasRelatedWork W4250889109 @default.
• W3094587340 hasVolume "108" @default.
• W3094587340 isParatext "false" @default.
• W3094587340 isRetracted "false" @default.
• W3094587340 magId "3094587340" @default.
• W3094587340 workType "article" @default.